| Ro60-Roles in RNA Processing, Inflammation, and Rheumatic Autoimmune Diseases RS Mahla, EL Jones, LB Dustin Preprints, 2024 | | 2024 |
| Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral Infection K Mader, LB Dustin Antibodies 13 (2), 28, 2024 | | 2024 |
| COVID‐19 vaccination and autoimmunity: Do we need more evidence? RS Mahla, LB Dustin Journal of Medical Virology 96 (4), e29623, 2024 | | 2024 |
| Comparison of different methods for isolating CD8+ T lymphocyte‐derived extracellular vesicles and supramolecular attack particles AK Jainarayanan, J Capera, PF Céspedes, M Conceição, ... Journal of Extracellular Biology 2 (3), e74, 2023 | 3 | 2023 |
| Lessons from a large-scale COVID-19 vaccine trial RS Mahla, LB Dustin The Journal of Clinical Investigation 132 (18), 2022 | 5 | 2022 |
| Searching for escape-resistant anti-SARS-CoV-2 neutralizing antibodies RS Mahla, LB Dustin J Clin Invest 132 (5), e157416, 2022 | 2 | 2022 |
| Searching for escape-resistant anti-SARS-CoV-2 neutralizing antibodies RS Mahla Journal of Clinical Investigation, 2022 | 2 | 2022 |
| TRIM21/Ro52 - Roles in Innate Immunity and Autoimmune Disease EL Jones, SM Laidlaw, LB Dustin Frontiers Immunology 12, 738473., 2021 | 53 | 2021 |
| An HCV vaccine on the fly SM Laidlaw, LB Dustin The Journal of Infectious Diseases 221 (8), 1216-1218, 2020 | 5 | 2020 |
| Tumor necrosis factor inhibits spread of hepatitis C virus among liver cells, independent from interferons SM Laidlaw, S Marukian, RH Gilmore, SB Cashman, V Nechyporuk-Zloy, ... Gastroenterology 153 (2), 566-578. e5, 2017 | 32 | 2017 |
| Innate and adaptive immune responses in chronic HCV infection L B Dustin Current drug targets 18 (7), 826-843, 2017 | 81 | 2017 |
| Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy LB Dustin, B Bartolini, MR Capobianchi, M Pistello Clinical microbiology and infection 22 (10), 826-832, 2016 | 106 | 2016 |
| MAIT cells are activated during human viral infections B Van Wilgenburg, I Scherwitzl, EC Hutchinson, T Leng, A Kurioka, ... Nature communications 7 (1), 11653, 2016 | 486 | 2016 |
| Recent advances in HBV and HCV immunology LB Dustin, N Trehanpati Frontiers in Immunology 6, 453, 2015 | 2 | 2015 |
| The humoral immune response to HCV: understanding is key to vaccine development SB Cashman, BD Marsden, LB Dustin Frontiers in immunology 5, 550, 2014 | 89 | 2014 |
| Interferon lambda: opportunities, risks, and uncertainties in the fight against HCV SM Laidlaw, LB Dustin Frontiers in immunology 5, 545, 2014 | 27 | 2014 |
| Genome-wide association study of hepatitis C virus-and cryoglobulin-related vasculitis AL Zignego, GL Wojcik, P Cacoub, M Visentini, M Casato, A Mangia, ... Genes & Immunity 15 (7), 500-505, 2014 | 70 | 2014 |
| Immune control and failure in HCV infection—tipping the balance LB Dustin, SB Cashman, SM Laidlaw Journal of leukocyte biology 96 (4), 535-548, 2014 | 62 | 2014 |
| THU0505 Characterization of Phenotype and Immunoglobulin Genes of Autoreactive B Cells in SjÖGren's Syndrome P Efthimiou, S Kadavath, A Bhatta, E Charles, L Dustin Annals of the Rheumatic Diseases 73 (Suppl 2), 358-358, 2014 | | 2014 |
| Selection of apoptotic cell specific human antibodies from adult bone marrow C Grönwall, ED Charles, LB Dustin, C Rader, GJ Silverman Plos one 9 (4), e95999, 2014 | 3 | 2014 |
